Presentaties ISMC - RLS

217 important questions on Presentaties ISMC - RLS

What is the oral treatment for RLS with low serum ferritin levels?

  • Ferrous sulfate 325 mg combined with vitamin C 100 mg twice a day
  • Effective for RLS in patients with serum ferritin level ≤ 75 mg/L
  • Based on one Class II study, Level C

What hormonal changes occur in pregnancy related to RLS?

  • Prolactin, estrogen, and progesterone levels rise, especially in the third trimester.
  • Prolactin correlates with PLMs; secretion increases after delivery.
  • Estradiol suppresses dopamine production/release.
  • Progesterone enhances neuronal excitability, peaking in the third trimester, possibly causing hyperreflexia and leading to PLMs and RLS.

Describe the intravenous treatment for moderate to severe RLS.

  • Ferric carboxymaltose 1000 mg is effective for moderate to severe RLS
  • Serum ferritin level < 300 mg/L with transferrin saturation < 45%
  • Supported by two Class I studies, Level A
  • Higher grades + faster learning
  • Never study anything twice
  • 100% sure, 100% understanding
Discover Study Smart

How does transient RLS during pregnancy impact future RLS risk?

  • Transient RLS in pregnancy increases chronic RLS risk fourfold compared to those who never had RLS during pregnancy.
  • RLS in one pregnancy boosts future pregnancy RLS risk by nineteen times.

What is the prevalence and trend of RLS in pregnancy?

  • 21% prevalence in pregnancy, higher than general population.
  • Higher trend as trimesters progress:
    • Trimester I: 8%
    • Trimester II: 16%
    • Trimester III: 22%

What does the graph on secondary RLS during pregnancy indicate?

  • Secondary RLS: Associated with pregnancy.
  • IRLS Scale: Peaks around 30 weeks.
  • Hemoglobin (Hb): 7.9 g/dl at peak.
  • Ferritin Level: 85 mcg/l.
  • Trend: Decrease after 40 weeks.

How do RLS symptoms change post-partum, and what role does iron deficiency play?

  • Mostly rapid remission post-partum.
  • Prevalence drops to 4%.
  • Persistent cases existed before pregnancy.
  • No lower ferritin levels in pregnant women with RLS versus without.

What does the graph indicate about RLS during pregnancy and related blood metrics?

  • Secondary RLS: Associated with pregnancy.
  • IRLS Scale Increase: Peaks around 30 weeks at above 30.
  • Decline by 50 Weeks: Falls below 20.
  • Hb Level: 7.5 mmol/l.
  • Ferritin Level: 45 mcg/l.

What are the key features of Secondary RLS associated with pregnancy according to the graph?

  • Secondary RLS: Associated with pregnancy.
  • Weeks: Symptoms appear from 20 weeks.
  • IRLS Scale: Starts at 20, increases to ~30.
  • Iron Supplementation: Administered around 30 weeks.
  • Delivery Details:
    • Blood loss: 850 cc.
    • Hemoglobin: 5.9 mmol/L.
    • Ferritin: 150 mcg/L.

What does the graph illustrate about RLS and pregnancy?

  • Title: RLS associated with pregnancy
  • IRLS Scale: 20
  • Weeks pregnant: ~20
  • Treatment started: Ferrofumerate 3 times a day, 200 mg

What does the graph show about the serum ferritin levels in an RLS patient during pregnancy?

  • A young woman with moderate-to-severe RLS experienced fluctuations in serum ferritin levels.
  • After intravenous iron (IV iron) treatment, levels increased significantly.
  • RLS symptoms remitted.
  • During pregnancy, RLS relapsed, coinciding with lower ferritin levels.

What are the teratogenic effects of Levodopa/carbidopa in pregnancy?

  • Class: C
  • Effects: Limited human data; causes visceral and skeletal malformations in animal studies (rabbits).
  • Keywords: Levodopa, carbidopa, visceral malformations, skeletal malformations.

How does Pramipexole affect pregnancy?

  • Class: C
  • Effects: Inhibits prolactin synthesis, diminishing lactation.
  • Keywords: Pramipexole, dopamine, prolactin, lactation.

What are the steps for accurately diagnosing RLS/WED?

  • Confirm 4 of 4 core RLS/WED features.
  • Rule out mimics, like cramps and edema.
  • Assess severity: frequency and impact.
  • Check for comorbid depression.

What kind of therapy would you consider for a 28-year-old female?

  • Cognitive Behavioral Therapy (CBT): Effective for anxiety and depression.
  • Dialectical Behavior Therapy (DBT): Helps manage emotions.
  • Psychodynamic Therapy: Explores past influences.
  • Group Therapy: Provides peer support.

What nonpharmacologic strategies are recommended for RLS/WED during pregnancy?

  • Educate on natural course during pregnancy.
  • Assess iron status.
  • Moderate-intensity/low-impact exercise.
  • Avoid exacerbating factors.
  • Consider other interventions.

What are the pregnancy risks associated with Clonazepam?

  • Class: D
  • Effects: Risk of birth defects, fetal dependency, floppy baby syndrome; neonatal withdrawal when used late in pregnancy.
  • Keywords: Clonazepam, benzodiazepines, birth defects, fetal dependency, floppy baby syndrome.

What are the main complaints of the 28-year-old pregnant woman related to her sleep and leg sensations?

  • Progressive bad sleep over 4-6 weeks.
  • Paresthesia in calves and upper legs, both sides.
  • Irresistible urge to move legs in bed, evening.
  • Movement eases the urge.
  • Tiredness without excessive sleepiness.
  • Concern for fetus development due to sleep deprivation.

How should iron levels be assessed and addressed in RLS/WED treatment?

  • Check hemoglobin, ferritin, iron, TIBC, % saturation.
  • Ferritin >75 mcg/L: continue oral iron.
  • Ferritin

Describe the effects of Oxycodone during pregnancy.

  • Class: B (D if chronic)
  • Effects: Neonatal withdrawal syndrome; sedation in newborns when excreted in breast milk.
  • Keywords: Oxycodone, neonatal withdrawal, sedation, breast milk.

What symptoms and history are noted for the 28-year-old female?

  • Symptoms:
    • Uncomfortable feeling in legs
    • Urge to move
    • Sleeping problems (4-6 weeks)
  • History:
    • Pregnant 21 weeks
  • No medication or intoxication mentioned.

What treatments are suggested for refractory RLS/WED during pregnancy?

  • Carbidopa/levodopa ER 25/100 to 50/200 mg in the evening/night.
  • Low-dose clonazepam 0.25 to 1 mg in the evening.
  • Severe cases: consider low-dose oxycodone.
  • Reassess periodically, reassess at delivery.

What are the effects of Methadone on pregnancy?

  • Class: B/C; D if high dose
  • Effects: No congenital defects; risks of low birth weight, neonatal withdrawal, sudden infant death.
  • Keywords: Methadone, birth weight, withdrawal, infant death.

What is the guidance for RLS/WED treatment during lactation?

  • Reassess iron status.
  • Gabapentin 300 to 900 mg in the evening/night.
  • Low-dose clonazepam 0.25 to 1 mg in the evening.
  • Very severe cases: consider low-dose tramadol.

What concerns exist for Clonidine use in pregnancy?

  • Class: C
  • Effects: Inadequate human studies; excreted in human milk.
  • Keywords: Clonidine, human studies, milk.

What were the results after three months for the 7-year-old patient?

  • Ferritin levels reached 60 mcg/l.
  • Symptoms showed improvement: more restful in the evening and better sleep initiation.
  • Iron supplementation was stopped to evaluate the patient further.

Why should dopamine-related treatments be avoided during lactation for RLS/WED?

  • Dopamine inhibits prolactin production.
  • Levodopa and dopamine agonists should not be used due to lactation interference.

How are Folate and Iron used during pregnancy?

  • Class: A
  • Effects: Essential nutrients; used in prenatal multivitamins.
  • Keywords: Folate, Iron, nutrients, multivitamins.

What is the role of Magnesium in pregnancy?

  • Class: B
  • Effects: Used in treating eclampsia; may benefit RLS.
  • Keywords: Magnesium, eclampsia, RLS.

What treatments and outcomes were observed in the 7-year-old with low ferritin levels?

  • Ferritin was 25 mcg/L, sat 16%.
  • Iron levels (iron, Hb, MCV, MCH, MCHC) were normal.
  • Serum ferritin > 50 ug/ml showed improvement with iron therapy.
  • Administered 3 mg/kg/day elemental ferrous iron sulfate for 3 months.
  • Dosage tapered over 1 year.
  • Improvements in iron levels and limb movements for up to 2 years.
  • IV iron supplementation showed promising results.

What are the current considerations for pediatric RLS treatment?

  • No FDA/EMA approved drugs for pediatric RLS.
  • Gabapentin and clonazepam used off-label.
  • Dopaminergic agonists limited to pediatric sleep specialists.
  • Assess iron levels; treat with oral ferrous sulfate if needed.

What is the association between iron levels and ADHD?

  • Oral iron supplementation partially improved ADHD symptoms (Server et al., 1997).
  • Lower ferritin levels were observed in ADHD patients compared to controls (Konofal et al., 2004).
  • Serum [Ferritine] was inversely correlated with ADHD severity (Konofal et al., 2004).

Describe the symptoms and diagnosis consideration process for RLS in children.

  • Symptoms include an urge to move legs, worse in evenings/rest.
  • Diagnosis considers family history, restlessness, sleep disturbances.
  • Evaluate daytime symptoms, comorbidities, recommend nonpharmacological interventions.

How is iron deficiency addressed in children with RLS?

  • Measure fasting iron and ferritin levels.
  • If levels are

What is the effect of MPH on RLS and PLMS in patients with ADHD?

  • RLS (+ ADHD) effects with MPH have never been measured.
  • MPH reduces PLMI in ADHD patients.
  • Research by Sobanski et al., 2008.

How does dopamine affect RLS and ADHD?

  • RLS and PLMS improve with dopamine.
  • Dopamine does not improve ADHD symptoms.

What are the connections between RLS and ADHD in children?

  • RLS in children can lead to sleep deprivation.
  • Sleep deprivation may cause ADHD-like symptoms.
  • RLS and ADHD share symptoms, risking misdiagnosis.
  • They have shared pathophysiology:
    • Dopaminergic pathophysiology
    • Iron deficiency

What is the relationship between PLMS and ADHD in children?

  • PLMS occurs in 44% of children with ADHD (up to -90%).
  • ADHD is linked to 26%-64% prevalence of PLMS.
  • 15% of ADHD children have PLMS, compared to 0% in controls.

What are the percentages of RLS and ADHD in children and adults?

  • Children:
    • RLS: 2 - 3.6%
    • ADHD: 3 - 6%
  • Adults:
    • RLS: 5 - 10%
    • ADHD: 1 - 2%

How prevalent is RLS among children according to the data?

  • RLS is present in 63%-74% of children.
  • Studies emphasize a link between PLMS, ADHD, and RLS.

What are the diagnostic criteria for Restless Legs Syndrome (RLS) in children?

  • Urge to move due to uncomfortable sensations in the legs.
  • Symptoms worsen during rest.
  • Symptoms are relieved by movement.
  • Worse in the evening or night.
  • Not due to other conditions (e.g., myalgia, arthritis).
  • Children should describe symptoms in their own words.

What are the percentages of RLS in ADHD and ADHD in RLS for children and adults?

  • Children:
    • RLS in ADHD: 6.8 - 44%
    • ADHD in RLS: 10.3 - 25%
  • Adults:
    • RLS in ADHD: 20 - 34.5%
    • ADHD in RLS: 8.5 - 27.6%

What are the symptoms and treatment details for the 7-year-old's ADHD?

  • Age: 7 years
  • Medication: MPH 2 dd 10 mg
  • Symptoms:
    • Excessively fidgets or squirms
    • Difficulty remaining seated
    • Easily distracted
    • Difficulty focusing
    • Difficulty waiting turn
    • Interrupts/blurts out answers
    • Difficulty following instructions
    • Difficulty sustaining attention
    • Moves from one activity to another, often not completing
    • Often talks excessively
    • Often loses things
    • Engages in seemingly dangerous activities
  • Improvement: Better during the day, not in the evening

What are the essential criteria for diagnosing Restless Legs Syndrome (RLS)?

  • Urge to move/dysaesthesia:
    1. Begins/increases at rest
    2. Relieved by movement
    3. Worse in evening/night
  • Not solely due to another condition
  • Causes concern, distress, sleep disturbance

What symptoms and behaviors suggest Restless Legs Syndrome in a 7-year-old?

  • Pain in legs during bedtime, requiring leg rubbing.
  • Difficulty initiating sleep.
  • Crying and rubbing lower legs at 19:00.
  • Must move around to relieve pain.
  • Occurs 3-4 times a week, lasts 1 hour.
  • Mother was recently diagnosed with RLS.
  • Describes pain as burning when wanting to sleep.

What associated criteria are considered when diagnosing RLS?

  • PLMS & PLMW are uncertain
  • Effect of dopaminergic medication is uncertain
  • Positive family history (1st grade) is present
  • Lack of sleepiness during the day is present

What are the main issues and history of the 7-year-old male patient?

  • Sleep Problems:
    • Difficulty initiating and maintaining sleep
    • Tossing and turning
    • Painful legs
  • History:
    • Diagnosed with ADHD
  • Medication:
    • Methylphenidate 2 times daily, 10 mg

What is the main topic presented in the text?

  • The main topic is children.
  • The information provided is minimal, focusing solely on the word children.

What changes and outcomes were implemented for Bart regarding dopamine wreck at age 56?

  • Gabapentin: Switched, side effects, little RLS effect.
  • PSG and POSA performed.
  • Ferritin: 36ug/L, oral substitution with low vitamin C.
  • CBT: Implemented.
  • Longacting DA: Not well tolerated.
  • Sifrol: 0.25mg twice daily.
Outcomes:
  • Impulses manageable, side effects gone.
  • Mood and anxiety improved.
  • Insomnia and IRLS scale improved.

What are the common side effects of dopamine agonists?

  • Nausea/vomiting
  • Fluid retention
  • Insomnia
  • Hypersomnia
  • Nasal congestion
  • Hallucinations
  • Morning rebound of symptoms
  • Augmentation

What are some key points about Impulse Control Disorders related to dopamine agonists?

  • Reported with dopamine agonists; approximately 17%
  • Examples: pathologic gambling, impulsive shopping, sorting, hoarding, hypersexuality
  • Occur ~9 months after starting medication
  • Discussed at each follow-up visit

What are the serious side effects of dopamine agonists?

  • Sleep Attacks
  • Orthostatic Hypotension
  • Compulsive Behaviors
  • Augmentation
  • Dyskinesia
  • Hallucinations

What medications has Bart switched between for his condition?

  • Several switches: Sifrol, Glepark, Oprymea, Pramipexol.
  • Currently uses: glepark 0.25mg.
  • Doses: One and a half tablet twice daily at 17:00 and 23:00.

What treatment was initially given to Bart for OSA and what medication was started?

  • Treated OSA with PAP.
  • Started on Sifrol 0.125mg twice daily.

When do Bart's restless leg symptoms typically begin?

  • Restless leg symptoms start at 15:00.
  • Occasionally feels sensations in his arms related to the symptoms.

What are the essential criteria for diagnosing Restless Legs Syndrome (RLS)?

  • Urge to move/dysaesthesias:
    1. Begins or increases at rest (+)
    2. Relieved by movement (+)
    3. Worse in the evening/night (+)
  • Not solely due to another condition (+/-)
  • Symptoms cause concern/distress, sleep disturbance, or daytime impairment (++++)

What side effects did Bart experience after several years of medication?

  • Increased libido for 8 months.
  • Involuntary movements leading to earlier medication intake.
  • Sleepiness post-medication and during day.
  • Auditive and sensory hallucinations.
  • Fluid retention in legs.
  • Headaches.
  • Hypotension.

What changes has Bart experienced relating to snoring and PAP usage?

  • He no longer snores after losing some weight.
  • Stopped using PAP 2-3 years ago.
  • Reasons: Leakage and comfort problems.

What factors contribute to Bart's insomnia?

  • Insomnia partly due to Restless Leg Syndrome (RLS).
  • Mainly due to feelings of guilt and anxiety.

What symptoms and issues does Bart, age 56, experience with his leg sensation condition?

  • Referral by GP.
  • Soda pop sensation in legs, either or both.
  • Walking or getting out of bed relieves symptoms.
  • Present during sleep onset for 15 years.
  • Starts before dinner for 2 years, 5/7 nights.
  • Results in severe social implications and variable insomnia.

What are the associated criteria for Restless Legs Syndrome (RLS)?

  • PLMS & PLMW (+)
  • Effect of dopaminergic medication (+)
  • Positive family history (1st grade) (+)
  • Lack of sleepiness during the day (+)

What does "Dopamine Wreck" in the context of RLS indicate?

  • Restless Leg Syndrome is linked to dopamine issues.
  • Symptoms can include:
    • Uncontrollable repetitive behaviors
    • Hypersensitivity to reward
    • Impaired quality of life
    • Activities: Sex, Shopping, Binge eating, Gambling

What steps should be taken in mild augmentation for restless legs syndrome?

  • Split dose
  • Advance dose or switch to α2δ ligand
  • Increase dose within limits, or switch to long-acting dopamine agonist

How is Restless Leg Syndrome (RLS) related to pregnancy?

  • RLS can be common in pregnancy.
  • Hormonal changes might contribute.
  • Effects can include:
    • Sleep disturbances
    • Discomfort in legs
    • Need for lifestyle adaptations

What is augmentation in the context of RLS symptoms due to medication?

  • Increase in one or more RLS symptoms due to medication.
  • Frequency: Symptoms occurring more often.
  • Duration: Symptoms lasting longer.
  • Number of body parts affected: More areas impacted.
  • Intensity: Symptoms become stronger.

How is severe augmentation managed according to the flow chart?

  • Eliminate short-acting dopamine agonist
  • Choose long-acting dopamine agonist or α2δ ligand
  • Cross-titration, switch, or drug holiday

How is Restless Leg Syndrome observed in children?

  • Children can also develop RLS.
  • Symptoms may include:
    • Discomfort in legs
    • Urge to move, especially at night
    • Impacts on sleep and behavior

What issues did Peter, 74, experience during travel?

  • Winter Holiday to Austria: Restless Leg Syndrome (RLS) returned.
  • Roadtrip to Spain: RLS came back again.

What preliminary checks and modifications are advised before addressing augmentation?

  • Check serum ferritin levels
  • Eliminate exacerbating factors, including low ferritin (

What does Peter's polysomnography (PSG) data indicate at age 74 while on Methadone?

  • General Hypopnea: Detected
  • Obstructive Apnea: Present
  • Mixed Apnea: Observed
  • Central Apnea: Present
  • SpO2 Desaturation: Significant
  • PLM (Periodic Limb Movement): Occurences present
  • Snore Events: Identified

What were the results of Peter's treatment for severe RLS with augmentation?

  • On 5mg Methadone, no side effects.
  • RLS improved (IRLS scale 32 to 4).
  • Insomnia improved (ISI 16 to 1).
  • Rotigotine tapered slowly.
  • EDS reduced from 14 to 6.
  • Mixed sleep apnea improvement.

What were the results of Peter's lab tests and their implications?

  • Ferritin levels are >100ug/L, indicating high saturation.
  • Iron infusion is unsafe due to risk of overload.
  • Ferritin is lower than in 2020.

What are the components shown in the PSG on Oxy graph?

  • Hypnogram: Tracks sleep stages
  • Position Summary: Displays sleeping positions
  • SpO2: Measures oxygen saturation
  • General Hypopnea, Obstructive Apnea, Central Apnea, Mixed Apnea: Indicate breathing issues
  • RERA, Arousal, SpO2 Desat: Track sleep disruption
  • PLM: Monitors leg movements
  • Snore EM: Detects snoring

How did Gabapentin tapering affect Peter's condition?

  • Initial 2-3 weeks difficult.
  • Restless Leg Syndrome (RLS) improved slightly post-taper.
  • Insomnia worsened during tapering.

What are the hemoglobine and MCV values, and their reference ranges?

  • Hemoglobine: 10.1 mmol/l
    • Reference range: 7.3 - 10.7 mmol/l
  • MCV: 93 fl
    • Reference range: 81 - 96 fl

What is the impact of Zolpidem on Peter's sleep and its side effects?

  • Taken every 3rd night.
  • Provides 6 hours of sleep.
  • Nights without Zolpidem worsen insomnia.
  • Causes nausea and dizziness.

What steps were taken for Peter, 74 years old, to address his condition?

  • Explain and educate patient.
  • Check ferritin levels.
  • Taper gabapentin dosage.
  • Behavioral Sleep Therapy (CBTi with RLS knowledge).
  • Add Zolpidem medication.
  • MRA brace used intermittently; limited effect.
  • PAP not tolerated.
  • Conducted Polysomnography.

List the glucose levels and reference ranges for fasting and non-fasting states.

  • Glucose: 6.3 mmol/l
    • Non-fasting: 3.3 - 7.8 mmol/l
    • Fasting (Nuchter): 4.0 - 6.0 mmol/l

How does Zolpidem affect Peter's PLM condition according to his wife?

  • Enables him to sleep through PLMs.
  • Previously hindered sleep; would wake and get out of bed.

What medication adjustments were made for Peter?

  • Transition from Oxycodone to Methadone.
  • Taper Rotigotine patch.

What treatments were used for Peter, 74 years old, and what were their effects?

  • Ferrous fumarate: Used regularly.
  • Cannabis tea: Caused unpleasant feeling.
  • Pregabalin: No effect.
  • Inhibin: No effect.
  • Drug Holidays: Caused depression symptoms, last in Dec 2020.
  • Simvastatin: Stopped for 6 months; no effect on RLS or insomnia.
  • Levodopa/carbidopa: Occasional use.
  • Clonazepam: Used.

What are the sodium and potassium levels with their reference ranges?

  • Sodium (Natrium): 141 mmol/l
    • Reference range: 135 - 145 mmol/l
  • Potassium (Kalium): 4.1 mmol/l
    • Reference range: 3.5 - 5.0 mmol/l

What were the findings from Peter's previous medical workup?

  • No neurological abnormalities.
  • MR-lumbar spine: age-appropriate degeneration.
  • Polysomnography 2016: OSA, mandibular appliance.
  • Polysomnography 2020:
    • Sleep misperception: 6h 35m vs 3h 15m.
    • PLMI: 9.1/h (2.9 arousal index).
    • AHI: 4.8/h with MRA.
  • Ferritin (06-09-2020): 227 µg/L; iron parameters normal.

Provide the creatinine, GFR CKD-EPI values, and their reference ranges.

  • Creatinine (Kreatinine): 83 umol/l
    • Reference range: 62 - 106 umol/l
  • GFR CKD-EPI: 81 ml/min/1.73m²
    • Reference range: >60 ml/min/1.73m²

What treatments and lifestyle factors are noted for Peter, a 74-year-old with RLS?

  • Drug holidays: Several lasting 3 months, benefit up to 1.5 years.
  • Rotigotine: Higher dose might help but causes faster augmentation.
  • Oxynorm: Relieves RLS symptoms but doesn't improve sleep.
  • Gabapentin: Uncertain effect on symptoms.
  • Sleep issues: Daytime sleepiness, nighttime insomnia with/without RLS.
  • Lifestyle:
    • Alcohol: 0 units/week.
    • Smoking: Never smoked.
    • Caffeine/theine: None.
    • Drugs: None.

What are the urea and iron values along with their reference ranges?

  • Urea (Ureum): 5.6 mmol/l
    • Reference range: 2.9 - 7.5 mmol/l
  • Iron (IJzer): 28.6 umol/l
    • Reference range: 10.0 - 30.0 umol/l

Who is involved and what are the key questions posed for reflection?

  • Peter, 74 years old is involved.
  • Three questions:
    1. What do you think this is?
    2. What else would you like to know?
    3. What would you do?

State the ferritin, transferrin levels, and reference ranges.

  • Ferritin: 128 ug/l
    • Reference range: 25 - 250 ug/l
  • Transferrin: 2.3 g/l
    • Reference range: 2.0 - 4.1 g/l

What is the transferrin saturation percentage and its reference range?

  • Transferrin Saturation (Transferrine-verz.): 48%
    • Reference range: 20 - 50%

When and how was Peter diagnosed with RLS, and what treatment did he initially receive?

  • Debut at age 13; diagnosed at 25 with Restless Leg Syndrome (RLS) by GP.
  • Initially, no therapy was available.
  • Treatment began 15 years ago with Pramipexole (Sifrol).

What are the key considerations for using oral iron in the treatment of RLS?

  • Iron deficiency RLS:
    • Ferritin < 50-75 ng/ml
    • % Iron saturation < 16%
    • TIBC > 400%
    • Iron < 60 ng/ml
  • 325mg Ferrous Sulfate (65mg elemental iron)
    • Combine with low-dose Vitamin C
    • Maintain 2-hour interval with dopaminergic medication

How did Peter's RLS symptoms progress, and what changes were made to his treatment?

  • Strong fluctuations in symptoms; worse after age 50.
  • Switched to Rotigotine patches in 2014 as Pramipexole was ineffective.
  • Symptoms intensified, requiring higher doses.

What are the key components of dopaminergic therapy for RLS?

  • Dopamine agonists: Pramipexol, Ropinirol, Rotigotine.
  • Dosing: Schedule 2 hours before symptom onset.
  • Strategy: Lower and slower total dose.
  • Levodopa: Occasionally used due to high augmentation rate.

What are the guidelines for administering intravenous iron for RLS?

  • Use for patients with low/normal ferritin levels intolerant of oral iron
  • Rapid response needed (effect in 6 weeks)
  • No immediate effects expected
  • Iron dextran has an anaphylaxis risk
  • Monitor iron overload: % Iron saturation > 45%
  • Recheck serum ferritin every 3-4 months, then less frequently

Describe Peter's current symptoms and how they affect his daily life.

  • Symptoms start early afternoon, become painful in the evening.
  • Involuntary movements disturb sleep, affecting him and his wife.
  • Afraid to change medication or go to bed.

What lifestyle changes are recommended for severe IRLS scores?

  • Regular sleep/wake cycles
  • Regular exercise
  • Stop smoking
  • For severe cases: Importance of lifestyle adjustments and discussing RLS medication options.

When should α₂δ calcium channel ligands be considered for RLS treatment?

  • First-line when pain, anxiety, insomnia, or augmentation are factors.
  • More effective in symptom onset after 40+ years.
  • Includes Gabapentin, Gabapentin enacarbil, Pregabalin.

What medications is Peter currently using for his RLS and other conditions?

  • Simvastatin 20mg once daily
  • Montelukast 10mg once daily
  • Gabapentin 600mg twice daily
  • Oxycodone 5mg as needed
  • Oxycodone SR 10mg twice daily
  • Rotigotine patch 2mg/24hr

What are the treatment categories for a 48-year-old with varying severity on the IRLS scale?

  • Mild (0-10):
    • Lifestyle: Adjustments advised
    • Underlying disease: Evaluate and treat
    • Medication: Review current meds
    • RLS medication: Unlikely needed
  • Moderate (11-20):
    • Lifestyle: Encourage improvements
    • Underlying disease: Address conditions
    • Medication: Potential changes
    • RLS medication: Consider if symptoms persist
  • Severe (21-30):
    • Lifestyle: Significant changes recommended
    • Underlying disease: Critical treatment
    • Medication: Assess necessity for change
    • RLS medication: Likely needed
  • Very severe (31-40):
    • Lifestyle: Intense modification
    • Underlying disease: Urgent management
    • Medication: Discontinue harmful drugs
    • RLS medication: Essential intervention

Discuss the use of opioids in RLS treatment.

  • Short-acting: Codeine, oxycodone, hydrocodone (T₁/₂ 4 hrs), Propoxyphene (T₁/₂ 6 hrs).
  • Long-acting: Oxycontin (T₁/₂ 8-10 hrs), Methadone (T₁/₂ 16-22 hrs), Fentanyl patch (T₁/₂ 72 hrs).

What is the severity of RLS for a 48-year-old female and how is it measured?

  • Frequency: Daily
  • John Hopkins RLS Severity Scale (JHS):
    • 0: No RLS
    • 1: Bedtime/night complaints = Mild RLS
    • 2: 18.00 hrs complaints = Moderate RLS
    • 3: Afternoon/whole day complaints = Severe RLS
  • International RLS Scale:
    • 10-item scale: 28/40 = Severe RLS

What should be considered when using (non) benzodiazepines for RLS?

  • No preference: Clonazepam vs. others.
  • Short T₁/₂ advised to minimize side effects.
  • Particularly important for elderly.
  • Options: Temazepam, Zolpidem, Zopiclone.

What are the key details about a 48-year-old female with RLS?

  • Condition: Restless Legs Syndrome (RLS)
  • Type: Idiopathic
  • Family history: Present
  • Triggering features:
    • Medical history: S1 Radiculopathy
    • Physical examination: Normal
    • Blood examination: Hb, ferritin (85 mcg/l), CRP normal
    • Medication: None

What are the differences between S1 radiculopathy and RLS in a 48-year-old woman?

  • S1 radiculopathy:
    • One side (right)
    • Same anatomic location
    • Other sensation
  • RLS (Restless Leg Syndrome):
    • Two-sided (simultaneous/alternating)
    • Diverse locations (calves, upper legs, arms)
  • Physical examination shows no signs of radiculopathy.

What are the essential criteria for diagnosing Restless Legs Syndrome (RLS)?

  • Urge to move/dysaesthesia
    1. Begins or increases at rest
    2. Relieved by movement
    3. Worse in the evening/night
  • Not solely due to another condition
  • Causes concern, distress, or daytime impairment

What is the difference in prevalence of PLMS between those with RLS and healthy individuals?

  • PLMS is more common in individuals with RLS than in healthy individuals.
  • PLMS is significantly larger in the RLS group.
  • In healthy people, only minor representation indicates the presence of LMS.

What are the associated criteria linked with Restless Legs Syndrome (RLS)?

  • PLMS & PLMW present
  • Effect from dopaminergic medication (unclear)
  • Positive 1st-grade family history
  • Lack of sleepiness during the day

What information is provided in the limb movement analysis?

  • Limb Movements (LM):
    • Total Number: 113
    • Rate: 31.8/hour
  • Periodic Limb Movements (PLM):
    • Total Number: 97
    • Rate: 27.3/hour
    • With Arousal: 21.4/hour
  • Mean Duration:
    • Full: 2.5-2.6s
  • Interval:
    • PLM Mean Interval: 30.2 seconds
  • Index:
    • Periodicity Index: 0.877

How does the prevalence of PLMS change with age?

  • 20 – 40 years: Prevalence of PLMS is around 10%.
  • 40 – 60 years: Increases to approximately 30%.
  • Over 60 years: Prevalence exceeds 40%.

What are the essential criteria for diagnosing Restless Leg Syndrome (RLS)?

  • Urge to move/dysaesthesias:
    1. Begins or increases at rest
    2. Relieved by movement
    3. Worse in the evening/night
  • Not accounted for by other conditions
  • Symptoms cause concern, distress, or impairment

What health factors might be associated with a 48-year-old woman smoking 20 cigarettes per day?

  • Possible Restless Legs Syndrome association.
  • Intoxication: 20 cigarettes/day.
  • Family history: Mother and daughter with similar complaints.

What are the associated criteria for Restless Leg Syndrome (RLS)?

  • PLMS & PLMW: Uncertain
  • Effect of dopaminergic medication: Uncertain
  • Positive family history (1st grade): Present
  • Lack of sleepiness during the day: Present

What are the key symptoms and characteristics described for the 48-year-old patient?

  • Symptoms since age 37
  • Itching in calves, urge to move
  • Symptoms worsen at rest
  • Start late afternoon (17:00 PM)
  • Movement alleviates symptoms
  • Frequency increased to 5-6x/week
  • Intensity VAS 8/10
  • Sleep initiation/maintenance issues
  • Daytime tiredness, no EDS

What are the key issues experienced by the 48-year-old female patient?

  • Problems initiating and maintaining sleep
  • Daytime tiredness
  • Potential restless legs
  • History includes Radiculopathy S1 R (1998) and tonsillectomy
  • No current medication

What are some nonpharmacological treatment options for RLS to try?

  • Cold/hot baths or showers
  • Massage
  • Relaxation/Yoga
  • Mental engagement
  • Light to moderate exercise
  • Appropriate sleep-wake schedule
  • CBT
  • Counter pressure

What are Eva's key health details and recommendations?

  • Age: 36 years
  • Ferritin levels: 118 μg/L
  • Caffeine intake: 14 units/day
  • Recommendation: Stop drinking coffee and black tea
  • Outcome: RLS acceptable, occasional sensations (~once a month)

What should be avoided in nonpharmacological treatment for RLS?

  • Nicotine, caffeine, alcohol
  • Antidepressants
  • Central-acting antihistamines
  • Dopaminergic antiemetics
  • Antipsychotics
  • Sleep deprivation
  • Excessive exercise

What is included in the essential criteria for Restless Legs Syndrome (RLS)?

Key factors for RLS include:
  • Urge to move/dysaesthesias:
    1. Begins/increases at rest
    2. Relieved by movement
    3. Worse in evening/night
  • Not solely another condition
  • Causes concern/distress/sleep disturbance

What are the essential criteria for diagnosing RLS according to the chart?

  • Urge to move or dysaesthesia:
    1. Begins or increases at rest
    2. Relieved by movement
    3. Worse in the evening/night
  • Not solely from another condition
  • Causes distress or daytime impairment

Describe the associated criteria for Restless Legs Syndrome (RLS).

Factors connected to RLS are:
  • PLMS & PLMW: Not specified
  • Effect of dopaminergic medication: Not specified
  • Positive family history (1st grade): Present
  • Lack of sleepiness during the day: Mixed presence

What are Eva's symptoms and previous treatments?

  • Insomnia since pregnancy of her 2-year-old boy
  • Keeps busy at night
  • Strange feelings in calves/feet
  • Tiredness and lack of energy during the day
  • Previous treatment:
    • Inhibin: no effect
    • Pramipexole 0.125mg: side effects

What are the associated criteria for RLS in the chart?

  • PLMS & PLMW
  • Effect of dopaminergic medication
  • Positive family history (1st grade)
  • Lack of sleepiness during the day

What are some common descriptions of Restless Legs Syndrome (RLS) symptoms?

Common Restless Legs Syndrome symptoms include:
  • Creeping and crawling
  • Restless and itching
  • Aching and searing
  • Tugging and drawing
  • Burning and electric
  • Current and painful
  • Soda pop and worms
  • Ants and bugs
  • Water flowing and indescribable

What are the ICSD-3 criteria for RLS?

  • Criteria A-C must be met for RLS diagnosis.
  • A: Urge to move legs with uncomfortable sensations.
    1. Worsens during rest.
    2. Relieved by movement.
    3. Predominantly in evening/night.
  • B: Not explained by another condition.
  • C: Causes distress or day function impairment.

What genetic and iron-related factors are associated with PLMS?

  • Genetic Factor: BTBD-9 gene
  • Iron Deficiency: Ferritin < 25 ng/ml found in ~40% of extreme PLMD cases

What conditions need careful exclusion when diagnosing PLMD?

  • Depression: a mental health disorder.
  • Insufficient sleep syndrome: chronic sleep limitation.
  • Circadian changes: disturbances in sleep-wake cycle.
  • Obstructive sleep apnea: blocked airway causing disrupted sleep.

What hypothesis related to CVR is associated with PLMS, and what changes occur before PLM?

  • Hypothesis (CVR): Not proven yet
  • Autonomic Function: Higher
  • Heart Rate and Blood Pressure: Increased
  • Arousal: ~40% before PLM

What are the diagnostic criteria for PLMD according to AASM 2014?

  • PLMI must be greater than 15 per hour.
  • Causes clinically significant sleep disturbance or impairment in functioning.
  • Symptoms not explained by another disorder, medical or mental.

How is extreme PLMD characterized and detected?

  • Characterized by: vigorous sleep behaviors (kicking, punching, gesticulations).
  • V-PSG (Video-Polysomnography) detects this via high PLMS index (~60/hr).
  • PLMS: periodic limb movements involving whole body, causing arousals.

What are the origins and consequences of PLMS according to the postulated model?

  • Origins:
    • Spinal Cord Hyperexcitability
    • Supraspinal Structures
    • Genetics
  • Consequences:
    • Arousals
    • Autonomic Features
    • Inflammation
    • Vascular Risk

What is the prevalence and clinical relevance of PLMS in the general population without sleep complaints?

  • Prevalence of PLMI > 15 is greater than 29%.
  • The prevalence increases with age.
  • It is often a common incidental finding.
  • Lacks apparent clinical relevance.

What should be considered when diagnosing the impact of PLMS on sleep or daytime functioning?

  • Assess the reasonable cause-effect relationship.
  • Do not diagnose PLMD if the only complaint is of being kicked during sleep.

What improvement occurs with dopaminergic medication in PLMD?

  • Enhances day and nighttime complaints.
  • Dopaminergic medication is the only drug that effectively suppresses PLMS (Periodic Limb Movements in Sleep).

In what conditions are PLMS found to be aspecific?

  • Common in:
    • Normal Healthy Persons
    • Narcolepsy, RBD, OSA
    • Neurodegenerative Disorders: MSA, PD, LBD, MS, Myelopathies, SCA
    • ESRF, Iron Deficiency Anemia
    • ADHD
    • Secondary to Medications: TCA, SSRI

What are the causes and treatments related to iron deficiency in RLS?

  • Brain iron deficiency is linked to:
    • Ferropenia and related conditions.
    • Downregulation of adenosine A1 receptors.
  • Treatments:
    • Oral or intravenous iron.
    • Dipyridamole increases extracellular adenosine and blocks ENT-reuptake mechanisms.

What treatments are used for pediatric Restless Legs Syndrome (RLS) when iron levels are below 50 µg/L?

  • Iron levels

How do dopamine and glutamate relate to RLS symptoms?

  • Hyperdopaminergic state:
    • Increased dopamine in corticostriatal pathways.
  • Hyperglutamatergic state:
    • Elevated glutamate in corticostriatal pathways.
  • Treatments include:
    • Selective AMPA-glutamate receptor antagonist Perampanel.
    • Alpha-2 delta ligands reduce glutamatergic release.

What is the prevalence and impact of RLS in childhood?

  • Prevalence ranges from 1-2%.
  • Age-appropriate language helps report symptoms.
  • Positive family history and PLMI >5/hr support diagnosis.
  • Causes sleep fragmentation.
  • Behavioral and educational functioning are mainly impacted.

Which drugs are off-label treatments for pediatric RLS, and what is FDA & EMA's stance?

  • No FDA/EMA-approved drugs for pediatric RLS.
  • Gabapentin and clonazepam: Used off-label as second-line options.
  • Dopaminergic agonists: Restricted to pediatric sleep specialists.

What are the clinical consequences and genetic factors of RLS?

  • Clinical consequences:
    • Sensitive symptoms (dysaesthesia).
    • PLMS (Periodic Limb Movements in Sleep).
    • Sleep disturbance and hyperarousability.
  • Genetic factors predispose individuals to RLS.
  • Dopamine agonists may be involved in treatment.

What are the teratogenic effects of Levodopa/carbidopa when used for restless legs syndrome (RLS) in pregnancy?

  • Class: C
  • Limited human data
  • Levodopa & combinations with carbidopa cause visceral & skeletal malformations in lab animals (rabbits).

How is secondary RLS in children identified and managed when associated with ADHD?

  • Secondary RLS: Associated with medications, kidney disease, anemia, neuropathy.
  • ADHD presence: Refer to a neurodevelopmental psychiatrist.
  • Use gabapentin or clonazepam.

Describe the effects of Pramipexole on pregnancy.

  • Class: C
  • Dopaminergic medication
  • Inhibits prolactin synthesis
  • Diminishes lactation

What are the steps for accurately diagnosing RLS/WED in pregnancy?

  • Confirm 4 key RLS/WED features.
  • Exclude mimics like leg cramps, edema.
  • Assess severity: frequency and impact.
  • Check for comorbid depression.

How should depression or anxiety associated with pediatric RLS be addressed?

  • Assess symptoms: Depression, anxiety.
  • Referral: Psychiatrist needed.
  • Consider nonpharmacological interventions alongside treatment.

What are some key points about RLS in pregnancy?

  • Affects 25% of pregnant women
  • First occurs during pregnancy for many
  • Severity increases with pregnancy progression
  • Symptoms drop/disappear post-delivery
  • 3rd most common cause of insomnia during pregnancy

What nonpharmacologic strategies are recommended for RLS/WED during pregnancy?

  • Educate about RLS/WED in pregnancy.
  • Assess iron status.
  • Engage in moderate-intensity exercise.
  • Avoid exacerbating factors.
  • Consider other interventions.

What are the effects of Clonazepam on pregnant women?

  • Class: D
  • Causes neonatal withdrawal syndrome if taken late in pregnancy
  • Increases risk of birth defects, fetal dependency, floppy baby syndrome after birth

What should be considered during a dopamine drug holiday?

  • Duration: Clearly define how long it will last.
  • Patient Communication: Thoroughly inform the patient about the process.
  • Depression/Anxiety: Be cautious of potential symptoms.
  • Psychological Guidance: Provide support if necessary.
  • Reality Check: Clarify that it's not an actual "holiday."
  • Post-Holiday Steps: Plan for the period after the break.

How is iron status assessed and treated in pregnant women with RLS/WED?

  • Check hemoglobin, serum ferritin, iron, TIBC, % saturation.
  • Ferritin >75 mcg/L: monitor.
  • Ferritin

How does Oxycodone affect pregnancy and newborns?

  • Class: B; Class D if chronic use
  • Causes neonatal withdrawal syndrome
  • Excreted in breast milk
  • Causes sedation in newborns

What are the prevention strategies for augmentation in RLS?

  • Maintain ferritin levels > 100 µg/l.
  • Avoid dopaminergic treatments if possible.
  • Use low, slow doses if needed.
  • Taper down in positive phases.
  • Strive for bearable RLS symptoms.
  • Inform the patient.
  • Make shared decisions.

What treatments are suggested for refractory RLS/WED in pregnancy?

  • Pregnancy: Carbidopa/levodopa, low-dose clonazepam.
  • Severe cases: low-dose oxycodone or tramadol.
  • Reassess medication periodically and at delivery.

What are the considerations for using Methadone in pregnancy?

  • Class: B/C; D if high dosage
  • No congenital defects increase
  • Risks: low birth weight, neonatal withdrawal, infant death syndrome
  • Compatible breastfeeding

What is known about the use of Clonidine in pregnant women?

  • Class: C
  • Inadequate studies in humans
  • Excretion in human milk

What is augmentation in the context of RLS?

  • Increase in RLS symptomatology
  • Symptoms spread to other body parts
  • Earlier onset during the day
  • Related to chronic dopaminergic therapy
  • Pseudo-progression may lead to incorrect strategies
  • After >6 months stable on treatment, clinical situation worsens

What are the treatment strategies for augmentation in RLS?

  • Reduce dopaminergic medication gradually.
  • Cross-titrate with alternatives:
    • Use Alfa 2 delta ligands.
    • Consider opioid treatment.

How is RLS/WED managed during lactation?

  • Reassess iron status.
  • Gabapentin: 300 to 900 mg in the evening/night.
  • Low-dose clonazepam if needed.
  • Severe cases: Consider low-dose tramadol.

When are opioids considered as a treatment option?

  • Used if the 3 first-line medicines did not help.
  • Can be used in mono or polytherapy.

How are Folate, Iron, and Magnesium supplements considered during pregnancy?

  • Folate: Class A, essential for multivitamin prep.
  • Iron: Class A, essential for multivitamin prep.
  • Magnesium: Class B, used for eclampsia, beneficial for RLS

What conditions are addressed by Alfa-2-delta ligand?

  • Anxiety
  • OCD
  • Insomnia
  • Neuropathic pain

What are the short acting opioid medications and their half-life?

  • Short-acting medications (TMax 30–60 minutes):
    • Codeine, oxycodone, hydrocodone (T1/2 4 hrs)
    • Propoxyphene (T1/2 6 hrs)

What conditions are addressed by Dopaminergica?

  • PLMS
  • Obesitas
  • Cognitive disorders
  • Depression/suicidal
  • Risk of falling

What are the dosage and pharmacokinetic properties of Gabapentin Enacarbil?

  • Dose: 600-1200mg
  • Tmax: 5-7 hrs
  • T1/2: Stable plasma levels 18-24 hrs, elimination half-life 6 hrs

What are the long acting opioid medications and their half-life?

  • Long-acting medications:
    • Oxycontin (T1/2 8-10 hrs)
    • Methadone (T1/2 16-22 hrs)
    • Fentanyl patch (T1/2 72 hrs)

What are the dosage and pharmacokinetic properties of Pregabalin?

  • Dose: 25-450mg
  • Tmax: 1.5 hrs
  • T1/2: Approximately 6 hrs

What are the key characteristics and side effects of dopaminergic drugs?

  • Ropinirol
    • Dose: 0.25-4 mg
    • Tmax: 2-3 hrs
    • T1/2: 6 hrs
  • Pramipexol
    • Dose: 0.125-0.75 mg
    • Tmax: 2-3 hrs
    • T1/2: 8-12 hrs
  • Rotigotine
    • Dose: 1-3 mg
    • Tmax: 1-3 hrs
    • T1/2: 5-7 hrs
  • Side effects: OCD and augmentation

What are the dosage and pharmacokinetic properties of Gabapentin?

  • Dose: 300-3600mg
  • Tmax: 2 hrs
  • T1/2: 6-8 hrs

What are key points to consider about oral iron supplementation?

  • Absorption is autoregulated by body iron stores.
  • Ferrous sulphate 325 mg taken 1-2 times daily with vitamin C.
  • 3 months and control serum levels advised.

What are the criteria for iron replacement therapy according to the given data?

  • Serum ferritin: < 100 ug/ml
  • Transferrin saturation: < 45%
  • Serum ferritin > 100 ug/ml: May still respond due to low brain iron despite higher peripheral iron.

When might IV iron be preferred over oral iron?

  • Presence of intestinal malabsorption (e.g., celiac disease).
  • Previous oral iron treatment failure or intolerance.
  • Need for faster response.
  • Use of Ferric carboxymaltose (FCM) 1,000 mg in single or divided doses.

What are the key serum tests and treatments involved in iron replacement therapy?

  • Serum tests:
    • Haemoglobin
    • Serum transferrin
    • Serum ferritin
    • Total iron-binding capacity
    • Serum iron
    • Transferrin saturation
    • Serum CRP
  • Treatment criteria:
    • Serum ferritin < 100 ug/ml
    • Transferrin saturation < 45%
    • Patients with serum ferritin > 100 ug/ml may also benefit due to low brain iron.

What are the pharmacological treatments listed?

The following treatments are mentioned:
  • Iron replacement therapy
  • Dopaminergic agents
  • Alfa 2 delta ligands
  • Opioids

What are some conservative treatments for insomnia?

  • Good sleep hygiene practice.
  • Behavioral strategies for alertness.
  • Avoid caffeine, nicotine, and alcohol.
  • Tactile stimulation via massage or hot baths.
  • Exercise programs.
  • Less evidence for behavioral therapy than in primary insomnia.
  • Comorbid insomnia may use CBT-I, avoid bedtime restriction.

What factors are considered in Step 3 for appropriate treatment of RLS?

Several factors determine appropriate treatment for Restless Legs Syndrome (RLS):
  • International RLS severity scale (0-40)
  • Frequency of symptoms
  • Time-onset RLS complaints
  • Effect on sleep and wake cycles
  • Comorbidity (important for drug choice)

What are the conservative measures for Restless Legs Syndrome (RLS) according to Step 2?

  • Optimal Treatment for Underlying Disorders:
    • Iron deficiency: ferritin < 75 µg/l
    • Pregnancy
    • Renal failure
  • Stop or Reduce RLS Inducing Medicine:
    • D2 antagonists (metoclopramide, prochlorperazine)
    • Traditional antipsychotics (phenothiazines)
    • Atypical neuroleptics (olanzapine, risperidone)
    • Antidepressants (norepinephrine/SSRIs)
    • Sedating antihistamines (diphenhydramine)
    • Possibly anticonvulsants (zonisamide, phenytoin, methosuximide)
    • Some benzodiazepines (chlordiazepoxide)

What are some known mimics of Restless Legs Syndrome (RLS)?

  • Polyneuropathy
  • Compression neuropathy
  • Akathisia
  • ADHD
  • Many more (Benes et al, Mov disorders 2007)

What are the steps in the management strategy for RLS?

  1. Confirm if it's RLS by excluding mimics.
  2. Address co-morbidities and adjust medications that may worsen or cause RLS.
  3. Choose treatment based on RLS severity and effectiveness, considering short and long-term outcomes (conservative vs. medication).

What are the co-morbidities or associations with RLS?

  • Sleep disorders
  • Neurological disorders
  • Medical disorders
  • Psychiatric disorders
  • Drug induced
  • Causal effect not always proved
  • Multimorbidity is a high-risk factor for RLS (OR 2.5-4.3 vs 1 comorbidity 1.3-1.6)
  • Cumulative disease burden is more important

What scales are used to quantify the clinical severity of Restless Legs Syndrome (RLS)?

  • International Restless Legs Syndrome Study Group (IRLSSG)
  • Self-Completed Restless Legs Syndrome Rating Scale
  • Johns Hopkins Restless Legs Severity Scale
  • RLS-6 scale
These scales help:
  • Quantify clinical severity at a single time point
  • Monitor medication effects

What are the steps involved in the diagnosis process mentioned?

  • Gather a typical history.
  • Conduct a (normal) neurological examination.
  • Exclude exacerbating medication.
  • Use PSG to identify PLMS.
  • Perform EMG.
  • Conduct a blood examination.

How do opioid receptor agonists and naloxone affect Restless Legs Syndrome (RLS)?

  • Opioid receptor agonists:
    • Improve RLS symptoms.
  • Naloxone (opiate receptor blocker):
    • Exacerbates RLS.

What are the effects of iron deficiency on A1-R cortico striatal regulation?

  • Iron deficiency leads to A1-R downregulation in the cortico striatal region.
  • Less inhibition on Glu results in increased glutamate release.
  • Downregulated A1-R decreases striatal dopamine release.
  • Results in less D1-R inhibition.

What hypothesis is suggested regarding central pain processing in Restless Legs Syndrome (RLS)?

  1. Central pain processing alteration:
    • PET studies indicate more severe RLS with higher release of endogenous opioids.
    • Post-mortem studies show decreased thalamic p-endorphins.

What are AMPA and NMDA receptors, and how do their inhibitors affect RLS?

  • AMPA and NMDA are two glutamate receptors.
  • NMDA inhibitors like ketamine and methadone improve RLS.
  • AMPA inhibitors such as perampanel also improve RLS.

How does iron deficiency affect medium spiny neurons (MSN)?

  • Causes hyperactivation of DIRECT pathway (medium spiny neurons are part of the gabenergic inhibitory cell).
  • Leads to inhibition of INDIRECT pathway (output structure is inhibition).
  • Final common result: spinal hyperexcitability.

How do opioid agonists function in relation to receptors involved in Restless Legs Syndrome (RLS)?

  • Opioid agonists:
    • Act on multiple receptors.
    • Include histamine, NMDA, and dopamine receptors, besides opioid receptors.

What are the cerebral and spinal regions associated with dopamine?

  • Cerebral Regions
    • Cortico
    • Striatum
  • Spinal Regions
    • Dorsal-posterior hypothalamus
    • A11 region

How do Alfa-2 delta ligands and voltage-gated Ca2+ channels influence RLS?

  • Alfa-2 delta ligands affect voltage-gated Ca2+ channels.
  • They exert presynaptic inhibition of glutamatergic transmission.
  • This action improves RLS symptoms.

Describe the differences in brain conditions with normal and deficient iron levels.

  • Normal conditions: Adequate A1-R regulation; balanced Glu and DA activities.
  • Iron deficiency: A1-R downregulation, increased Glu release.
  • Results in decreased DA levels; indirect MSN inhibition reduced.

What changes occur in the presynaptic hyperdopaminergic state in RLS patients?

  • Reduced fluoro-3,4-dihydroxyphenylalanine (f-DOPA) uptake
  • Increased tyrosine hydroxylase (TH) staining
  • Decreased dopamine transporter
  • Increased CSF biopterin and 3-ortho-methyldopa
  • Changes in dopamine D2 receptor (D2R) activity

What circuits and pathways are depicted in the diagram related to dopamine?

  • Circuits
    • Somatic circuits
    • Autonomic circuits
  • Pathways
    • Muscle afferents
    • Dorsal horn
    • Motoneurons
    • Postganglionics
    • High threshold
    • Low threshold
    • NA adrenaline
    • SSRIs
    • IML

What does the MRI study reveal about glutamate levels in RLS patients?

  • MRI studies show increased basal glutamate levels.
  • These increases are observed in the thalamus of patients with RLS.

What is the relationship between RLS prevalence and iron availability?

  • RLS prevalence is higher with insufficient iron availability.
  • Iron-deficient anemia RLS prevalence is 30%.
  • This is six times higher than the general population's RLS prevalence.

How does brain iron deficiency in rodents relate to dopaminergic profiles in RLS patients?

  • Striatal D2 receptor density decreases
  • Dopamine transporter (DAT) reduces
  • Phosphorylated tyrosine hydroxylase (TH) expression increases

What are common disease-common variant genetics and their associations?

  • Common disease-common variant approach
  • Not related to:
    • Protein coding
    • Candidate genes for RLS (iron metabolism)
  • Related to:
    • Regulatory regions
    • Neurogenesis
    • Neuronal differentiation
    • Axonal path finding
    • Synaptogenesis

Describe brain iron deficiency in the context of RLS.

  • Brain iron deficiency includes:
    • Reduced CSF ferritin (intracellular iron storage protein).
    • Elevated CSF transferrin levels (extracellular iron-carrier protein).
    • Normal serum levels of ferritin and transferrin in RLS.
    • Substantia nigra and thalamus show low brain iron levels.

What is the heritability percentage and nature of the disorder described in the genetics of pathophysiology?

  • Heritability: 50%-60%
  • Nature: Familial disease
  • Type: Complex multifactorial disorder
  • Factors: Genetic and non-genetic susceptibility

What causes a reduction in brain iron in RLS?

  • Causes include:
    • Epithelial cells of the choroid plexus affect iron transport.
    • Reduction of iron ferritin, up-regulation of transferrin receptor.
    • Iron transport via transferrin impaired in RLS.

What is the role of PLMS in spinal cord flexor reflex?

  • PLMS linked with acute spinal cord injuries.
  • No circadian pattern.
  • Not associated with cortical micro-arousals.

What are the findings related to GWAS in the context of pathophysiology genetics?

  • Risk Loci: MEIS1, BTBD9, PTPRD, MAP2K5, SKOR1, TOX3
  • Additional Loci: 13 new risk loci
  • Risk Increase: Each variant by ~50%
  • Heritability Explained: 19.6%

Describe spinal hyperexcitability and its mechanism.

  • Mediated by supraspinal mechanisms.
  • Lower threshold of flexor reflex during sleep.
  • Leads to spinal cord hyperexcitability.

What are the factors involved in the pathophysiology diagram?

  • Iron Deficiency leads to hypo-adenosinergic state and hyper-arousal.
  • BID and Genes lead to hyper-glutamatergic and hyper-dopaminergic states.
  • Dysfunction of C-S-T-C circuits results in PLMS/Akathisia.

How is sensory-motor integration affected in CSTC circuits?

  • TMS: Cortical hyperexcitability, reduced short-latency intra-cortical inhibition.
  • fMRI: Striatum, thalamus, frontal regions altered in RLS vs controls.
  • Decreased cortical thickness in sensory cortex, corpus callosum.

What are the features to consider for a comprehensive diagnostic assessment of Restless Legs Syndrome?

  • Gender
  • Age and age of onset
  • History of the course of the disease
  • Sleep disturbance
  • Degree of pain vs discomfort for RLS symptoms
  • Parts of the body involved
  • Daily pattern of symptoms and activity levels
  • History of pregnancy
  • History of iron deficiency

What occurs due to enhanced arousal state impairment?

  • Impaired neural mechanisms:
    1. Regulate the arousal-sleep drive.
    2. Govern sensory motor function.

What are the prevalences of RLS and PLMs in different age groups?

  • 20-40 years:
    • RLS: ~3%
    • PLMs: ~5%
  • 40-60 years:
    • RLS: ~5%
    • PLMs: ~25%
  • >60 years:
    • RLS: ~10%
    • PLMs: ~40%
  • PLMs are sensitive but not specific for RLS.

What are the genetic and developmental factors in this pathophysiology?

  1. Genetically modulated alterations in brain iron homeostasis.
  2. Developmental abnormalities of the cortico-striato-thalamo-cortical (CSTC) circuit.
  3. Increased dopaminergic and glutamatergic function.

What are the criteria for leg movement in PLMS according to the AASM?

  • Recorded using m. tibialis anterior bilateral surface electrodes.
  • Duration: 0.5-10 seconds.
  • Onset: 8 µV increase above resting EMG.
  • Offset: At least 0.5 seconds, not more than 0.2 µV above resting EMG.
  • Excluded: 0.5 seconds before/after respiratory events.

What are the essential criteria for Restless Legs Syndrome?

  • Urge to move and dysaesthesias
  • Increase at rest
  • Relief by movement
  • Worse in the evening
  • RLS mimic excluded

What defines periodic leg movements (LM) in sleep (PLMS)?

  • Requires at least 4 leg movements in a row.
  • Interval between movements: 5-90 seconds.
  • Association: Arousal and PLM are linked if

What defines chronic persistent and intermittent conditions in this classification?

  • Chronic – persistent:
    • Occurs when untreated.
    • At least 2 times per week over the past year.
  • Intermittent:
    • Occurs when untreated.
    • Less than 2 times per week for the past year.
    • At least five lifetime events.

How is the PLM Index calculated?

  • Represents the number of periodic leg movements per hour of sleep.

What supportive criteria help diagnose Restless Legs Syndrome?

  • Periodic Limb movements in sleep (PLMS)
  • Response to dopaminergic medication
  • Family history in 1st degree relatives
  • Lack of expected daytime sleepiness

What are the diagnostic criteria for Restless Legs Syndrome (RLS)?

Diagnostic criteria for RLS include:
  • A: Urge to move & dysaesthesias, increase at rest, relief by movement, worse in the evening.
  • B: RLS mimic excluded.
  • C: Impact assessment.

What disclosures are included in the presentation by ISMC?

  • There are no disclosures listed in the presentation.
  • The word "NONE" is used to indicate the absence of any disclosures.

Who presented on Restless Legs Syndrome and PLMS at ISMC 2022?

  • Presenter: Roselyne M. Rijsman, MD, PhD
  • Affiliation: Sleep Center
  • Institution: Haaglanden Medical Center
  • Location: The Hague, The Netherlands
  • Event: ISMC 2022

The question on the page originate from the summary of the following study material:

  • A unique study and practice tool
  • Never study anything twice again
  • Get the grades you hope for
  • 100% sure, 100% understanding
Remember faster, study better. Scientifically proven.
Trustpilot Logo